结果对47例患者进行随访，病死率、靶血管重建率和主要心脏事件发生率分别为2.1%、2.1%和6.4%。
ResultsFor follow-up 47 patients, the mortality, target vessel revascularization ratio and major adverse cardiac events were 2.1%, 2.1%, 6.4%.
心脏病发作和中风通常是急性事件，主要是由于堵塞导致血液不能流入心脏或脑部。
Heart attacks and strokes are usually acute events and are mainly caused by a blockage that prevents blood from flowing to the heart or brain.
冠心病病人CRP的影响因素及对主要不良心脏事件的预测。
The relative factors of CRP and prediction of major adverse cardiac events for coronary disease.
冠心病病人CRP的影响因素及对主要不良心脏事件（MACE）的预测。
The relative factors of CRP and prediction of major adverse cardiac events (MACE) for coronary disease (CHD).
研究者追踪主要的冠心病事件，包括心脏猝死，致命或者非致命性心脏病，以及其它非致命性心脏问题。在两组的平均追踪时间是4.6年。
Then the researchers tracked major coronary events, such as sudden cardiac death, fatal or nonfatal heart attack, or other nonfatal heart problems, in both groups for 4.6 years, on average.
主要的衡量结果为动脉粥样硬化性事件，包括致命的或非致命性缺血性心脏病，致命性的或非致命性中风及外周动脉疾病。
The main outcome measures were atherosclerotic events, including fatal or nonfatal ischemic heart disease, fatal or nonfatal stroke, and peripheral arterial disease.
主要终点事件包括心脏性死亡、Q波性心梗、再发心绞痛需要再次血运重建等。
The primary end point was defined as cardiac mortality, Q-wave myocardial infarction (MI), or refractory angina requiring revascularization.
30天和一年的住院期间，其主要结局是缓慢流动/无复流现象（SF-NR）的发生，临床终点包括死亡、心肌梗死（MI）、靶病变血管血运重建术（TVR）和主要心脏不良事件（MACE）。
The primary outcome was the occurrence of SF-NR Clinical endpoints included death, MI, target vessel revascularization (TVR), and MACE during the hospitalization period, 30 days and at 1 year.
30天和一年的住院期间，其主要结局是缓慢流动/无复流现象（SF-NR）的发生，临床终点包括死亡、心肌梗死（MI）、靶病变血管血运重建术（TVR）和主要心脏不良事件（MACE）。
The primary outcome was the occurrence of SF-NR Clinical endpoints included death, MI, target vessel revascularization (TVR), and MACE during the hospitalization period, 30 days and at 1 year.
应用推荐